Zobrazeno 1 - 10
of 30 115
pro vyhledávání: '"SMA"'
Publikováno v:
SMA Solar Technology AG MarketLine Company Profile. 10/21/2021, p1-25. 25p.
Publikováno v:
SMA Solar Technology AG MarketLine Company Profile. 5/29/2020, p1-25. 25p.
Publikováno v:
Robotic Intelligence and Automation, 2024, Vol. 44, Issue 6, pp. 830-840.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/RIA-11-2023-0162
Publikováno v:
Cell Adhesion & Migration, Vol 18, Iss 1, Pp 1-11 (2024)
We aimed to investigate galectin-1 overexpression induces normal fibroblasts (NFs) translates into cancer-associated fibroblasts (CAFs). Galectin-1 overexpression was conducted in Human embryonic lung fibroblasts (HFL1) cell. The motilities of H1299
Externí odkaz:
https://doaj.org/article/45bd411b7a7e47d5995a37643de20f3f
Autor:
Rukhsana Hassan, Gh Rasool Bhat, Feroze Ahmad Mir, Hilal Ahmad Ganie, Ifra Mushtaq, Mushtaq Ahmad Bhat, Ravouf Parvez Asimi, Dil Afroze
Publikováno v:
BMC Medical Genomics, Vol 17, Iss 1, Pp 1-8 (2024)
Abstract Spinal muscular atrophy (SMA) is a rare genetic disorder that unequivocally results in the degeneration of motor neurons, leading to muscle weakness and atrophy. This condition is caused by a mutation in the survival motor neuron 1 (SMN1) ge
Externí odkaz:
https://doaj.org/article/01e5f761270643aba885ff0b0b52a4d9
Autor:
Gianmarco Severa, Maria del Carmen Alfaro, Christophe Alimi Ichola, Hussein Shoaito, Sarah Souvannanorath, François-Jerôme Authier, Edoardo Malfatti
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Background Risdiplam is a validated treatment for adult SMA patients, but clear guidelines concerning functional assessment at baseline and during the follow-up are still limited, especially in terms of sensible and validated outcome measure
Externí odkaz:
https://doaj.org/article/69314ef67955413389a14a593c50a8b3
Autor:
P. Lizandra Cortés, D. Poveda Verdú, A. Albert Férriz, N.C. Ñungo-Garzón, M.C. Domine, T. Sevilla-Mantecón, I. Pitarch-Castellano, J.F. Vázquez-Costa
Publikováno v:
Neurología, Vol 39, Iss 9, Pp 733-742 (2024)
Resumen: Introducción: La atrofia muscular espinal 5q (AME) es una enfermedad genética neurodegenerativa que afecta a las motoneuronas alfa produciendo debilidad progresiva. Actualmente se precisan nuevas herramientas que permitan medir y caracteri
Externí odkaz:
https://doaj.org/article/407b92b240634272883fde48f25f7def
Autor:
Tomohiko Ishihara, Akihide Koyama, Naoki Atsuta, Mari Tada, Saori Toyoda, Kenta Kashiwagi, Sachiko Hirokawa, Yuya Hatano, Akio Yokoseki, Ryoichi Nakamura, Genki Tohnai, Yuishin Izumi, Ryuji Kaji, Mitsuya Morita, Asako Tamura, Osamu Kano, Masashi Aoki, Satoshi Kuwabara, Akiyoshi Kakita, Gen Sobue, Osamu Onodera
Publikováno v:
BMC Medical Genomics, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background The copy number status (CNS) of the survival motor neuron (SMN) gene may influence the risk and prognosis of amyotrophic lateral sclerosis (ALS) and lower motor neuron diseases (LMND) other than spinal muscular atrophy (SMA). Howe
Externí odkaz:
https://doaj.org/article/e6002aa4b2cd48bbb9179f2fb1b1a195
Autor:
Ana Lilia Torres-Machorro, Carina Becerril, Everardo Hernández-Plata, Erika Rubí Luis-García, Mariel Maldonado, Iliana Herrera, Miguel Negreros, Fernando Hernández-Sánchez, Criselda Mendoza-Milla, Miguel Gaxiola, Remedios Ramírez, Annie Pardo, Ivette Buendía-Roldán, Moisés Selman, José Cisneros
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Hypersensitivity pneumonitis (HP) is an immune-mediated inflammatory interstitial lung disease that may evolve to pulmonary fibrosis, a progressive disorder with a poor prognosis characterized by fibroblast activation and extracellular matri
Externí odkaz:
https://doaj.org/article/7289dbc72dcb4c04af56d49223beee3f